Gaps in Veterinary Pharmaceuticals and Pesticide Regulation: GMP Compliance, Postmarket Surveillance, and Institutional Reforms
Veterinary Medicine International · 2026-01 · 2026 (1)
DOI: 10.1155/vmi/9910034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Medicine International, online erschienen am 23.03.2026. Verfasst von Yesuneh Tefera Mekasha und 7 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In Ethiopia, veterinary pharmaceuticals and agricultural pesticides are vital to maintaining agricultural productivity and food security, yet their quality and safety regulation face significant challenges.
Objectives
This study aimed to assess the regulatory framework, institutional capacity, and routine quality assurance practices related to veterinary drugs and agricultural pesticides in Ethiopia. Problems in routine practices and common product defects were assessed.
Methods
Retrospective analysis of regulatory practice records (2017–2022), cross‐sectional stakeholder surveys, and focal regulatory expert discussions were employed to collect data. Data sources included were institutional postmarket surveillance and foreign good manufacturing practice (GMP) visit records, routine pesticide registration, and market authorization practices. Descriptive statistics are used to summarize findings on data collection and analysis.
Results
The GMP inspection records ( N = 79) revealed the experience of 20 major and 8 critical deficiencies, with 4.2% and 8.5% of observed deficiencies leading to company and production line rejections from market entry. Postmarket surveillance records reveal that 8.2% of veterinary drug samples fail to comply with required standards. Additionally, the observation for regulatory processes and practices showed inconsistencies in the use of reference standards and the absence of specific guidelines for regulatory decisions. Furthermore, the study revealed that the pesticide regulatory system lacked codified procedures and quality control infrastructure.
Conclusion
The study found that the country’s veterinary pharmaceutical and pesticide regulatory system exhibits critical weaknesses in GMP compliance, postmarket surveillance, and institutional coherences, contributing to the circulation of substandard products and environmental health risks. The study suggests that urgent reforms are required, including harmonized quality standards, investment in laboratory infrastructure, digital regulatory tools, strengthened interagency coordination, and stabilization of institutional mandates to align with international benchmarks and protect public health.
Zitieren
APA
Mekasha, Y. T., Hassen, H. K., Abraham, M., Shiferaw, M. A., Mengistu, D. A., Girma, Z. M., Nigussie, E. E., & Ozalp, Y. (2026). Gaps in Veterinary Pharmaceuticals and Pesticide Regulation: GMP Compliance, Postmarket Surveillance, and Institutional Reforms. Veterinary Medicine International, 2026(1). https://doi.org/10.1155/vmi/9910034
Vancouver
Mekasha YT, Hassen HK, Abraham M, Shiferaw MA, Mengistu DA, Girma ZM, et al. Gaps in Veterinary Pharmaceuticals and Pesticide Regulation: GMP Compliance, Postmarket Surveillance, and Institutional Reforms. Veterinary Medicine International. 2026;2026(1). doi:10.1155/vmi/9910034
BibTeX
@article{Mekasha2026,
author = {Mekasha, Yesuneh Tefera and Hassen, Hassen Kebede and Abraham, Mikael and Shiferaw, Mulukan Akalu and Mengistu, Dejene Asaye and Girma, Zerihun Mesfin and Nigussie, Eshet Emiru and Ozalp, Yildiz},
title = {Gaps in Veterinary Pharmaceuticals and Pesticide Regulation: GMP Compliance, Postmarket Surveillance, and Institutional Reforms},
journal = {Veterinary Medicine International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/vmi/9910034}
}
EUVIMED